FF30 Table-top Filling and Capping Machine
This semi-automatic filling and capping machine is ideal for flexible small scale production in diagnostics production, hospital pharmacies, R&D departments and general subcontract filling/finish companies. The speed of the FF30 is easily adjusted to match the working speed of the operator and liquids can be filled in volumes from 0.1ml to 100ml with +/-0.5% accuracy.
The Flexicon FF30 semi-automatic filling and capping machine is ideal for flexible small scale production. The speed of the FF30 can be adjusted to match the working speed of the operator and liquids can be filled in volumes from 0.1ml to 100ml with +/-0.5% accuracy.
Offering a capacity up to 1200 bottles per hour (depending on filling volume and operator), and able to handle bottles between 12mm and 50mm in diameter, key application areas for the FF30 include the diagnostic industry, hospital pharmacies, R&D departments, essential oil manufacturers, cosmetics producers and general subcontract filling/finish companies.
The FF30 ensures clean production without risk of cross-contamination; a consistent cap torque prevents any leakage of liquid, while a bottle/cap change takes a maximum of five minutes, helping improving uptime and productivity.
The machine’s small footprint makes it ideal for use in laminar air flow units or bio-safety cabinets.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
